Advertisement

Index by author

March 01, 1991; Volume 39,Issue 3

A

  1. Anundi, I

    1. Futile cycling of a sulfate conjugate by isolated hepatocytes.
      F C Kauffman, M Whittaker, I Anundi and R G Thurman
      Molecular Pharmacology March 1991, 39 (3) 414-420;

  2. Arneson-Rotert, L J

    1. Serum-induced sensitization of cyclic AMP accumulation in 1321N1 human astrocytoma cells.
      R A Johnson, L J Arneson-Rotert, J M Hoffman and M L Toews
      Molecular Pharmacology March 1991, 39 (3) 399-406;

  3. Audhya, T

    1. Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
      M Quik, H el-Bizri, T Audhya and G Goldstein
      Molecular Pharmacology March 1991, 39 (3) 324-331;

  4. Axelrod, J

    1. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
      R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
      Molecular Pharmacology March 1991, 39 (3) 364-369;

B

  1. Bell, K

    1. Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
      K Klijn, S R Slivka, K Bell and P A Insel
      Molecular Pharmacology March 1991, 39 (3) 407-413;

  2. Bianchi, B R

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  3. Birnbaum, L S

    1. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
      F H Lin, G Clark, L S Birnbaum, G W Lucier and J A Goldstein
      Molecular Pharmacology March 1991, 39 (3) 307-313;

  4. Blakeman, D P

    1. Correlation between gamma-aminobutyric acidA receptor ligand-induced changes in t-butylbicyclophosphoro[35S]thionate binding and 36Cl- uptake in rat cerebrocortical membranes.
      W B Im and D P Blakeman
      Molecular Pharmacology March 1991, 39 (3) 394-398;

  5. Boja, J W

    1. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
      J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar
      Molecular Pharmacology March 1991, 39 (3) 339-345;

  6. Briley, E M

    1. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
      R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
      Molecular Pharmacology March 1991, 39 (3) 364-369;

  7. Bürgin, M

    1. Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.
      J Huwyler, M Bürgin, T Zeugin and J Gut
      Molecular Pharmacology March 1991, 39 (3) 314-323;

  8. Burman, M

    1. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
      T J Torphy, H L Zhou, M Burman and L B Huang
      Molecular Pharmacology March 1991, 39 (3) 376-384;

C

  1. Caffrey, P B

    1. Inhibition of cell colony formation by selenite: involvement of glutathione.
      P B Caffrey and G D Frenkel
      Molecular Pharmacology March 1991, 39 (3) 281-284;

  2. Carroll, F I

    1. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
      J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar
      Molecular Pharmacology March 1991, 39 (3) 339-345;

  3. Castle, N A

    1. Block of single batrachotoxin-activated Na+ channels by clofilium.
      J Nettleton, N A Castle and G K Wang
      Molecular Pharmacology March 1991, 39 (3) 352-358;

  4. Clark, G

    1. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
      F H Lin, G Clark, L S Birnbaum, G W Lucier and J A Goldstein
      Molecular Pharmacology March 1991, 39 (3) 307-313;

  5. Cohn, J A

    1. cAMP analogs inhibit gamma-aminobutyric acid-gated chloride flux and activate protein kinase A in brain synaptoneurosomes.
      R D Schwartz, G Heuschneider, P P Edgar and J A Cohn
      Molecular Pharmacology March 1991, 39 (3) 370-375;

  6. Corcoran, G B

    1. Induction of cytochrome P450IIE1 in the obese overfed rat.
      J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran
      Molecular Pharmacology March 1991, 39 (3) 275-280;

  7. Craig, R

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

D

  1. Davis, M A

    1. Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.
      C E Dusenbury, M A Davis, T S Lawrence and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 285-289;

  2. Dusenbury, C E

    1. Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.
      C E Dusenbury, M A Davis, T S Lawrence and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 285-289;

E

  1. Edgar, P P

    1. cAMP analogs inhibit gamma-aminobutyric acid-gated chloride flux and activate protein kinase A in brain synaptoneurosomes.
      R D Schwartz, G Heuschneider, P P Edgar and J A Cohn
      Molecular Pharmacology March 1991, 39 (3) 370-375;

  2. el-Bizri, H

    1. Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
      M Quik, H el-Bizri, T Audhya and G Goldstein
      Molecular Pharmacology March 1991, 39 (3) 324-331;

F

  1. Felder, C C

    1. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
      R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
      Molecular Pharmacology March 1991, 39 (3) 364-369;

  2. Forman, S A

    1. Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo.
      S C Wood, S A Forman and K W Miller
      Molecular Pharmacology March 1991, 39 (3) 332-338;

  3. Frenkel, G D

    1. Inhibition of cell colony formation by selenite: involvement of glutathione.
      P B Caffrey and G D Frenkel
      Molecular Pharmacology March 1991, 39 (3) 281-284;

G

  1. Goldstein, G

    1. Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
      M Quik, H el-Bizri, T Audhya and G Goldstein
      Molecular Pharmacology March 1991, 39 (3) 324-331;

  2. Goldstein, J A

    1. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
      F H Lin, G Clark, L S Birnbaum, G W Lucier and J A Goldstein
      Molecular Pharmacology March 1991, 39 (3) 307-313;

  3. Gut, J

    1. Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.
      J Huwyler, M Bürgin, T Zeugin and J Gut
      Molecular Pharmacology March 1991, 39 (3) 314-323;

H

  1. Heuschneider, G

    1. cAMP analogs inhibit gamma-aminobutyric acid-gated chloride flux and activate protein kinase A in brain synaptoneurosomes.
      R D Schwartz, G Heuschneider, P P Edgar and J A Cohn
      Molecular Pharmacology March 1991, 39 (3) 370-375;

  2. Hoffman, J M

    1. Serum-induced sensitization of cyclic AMP accumulation in 1321N1 human astrocytoma cells.
      R A Johnson, L J Arneson-Rotert, J M Hoffman and M L Toews
      Molecular Pharmacology March 1991, 39 (3) 399-406;

  3. Huang, L B

    1. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
      T J Torphy, H L Zhou, M Burman and L B Huang
      Molecular Pharmacology March 1991, 39 (3) 376-384;

  4. Huwyler, J

    1. Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.
      J Huwyler, M Bürgin, T Zeugin and J Gut
      Molecular Pharmacology March 1991, 39 (3) 314-323;

I

  1. Im, W B

    1. Correlation between gamma-aminobutyric acidA receptor ligand-induced changes in t-butylbicyclophosphoro[35S]thionate binding and 36Cl- uptake in rat cerebrocortical membranes.
      W B Im and D P Blakeman
      Molecular Pharmacology March 1991, 39 (3) 394-398;

  2. Insel, P A

    1. Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
      K Klijn, S R Slivka, K Bell and P A Insel
      Molecular Pharmacology March 1991, 39 (3) 407-413;

  3. Itzhak, Y

    1. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
      Y Itzhak, D Mash, S H Zhang and I Stein
      Molecular Pharmacology March 1991, 39 (3) 385-393;

  4. Iwaniec, L M

    1. Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.
      L M Iwaniec, J J Kroll, W M Roethel and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 299-306;

J

  1. Johnson, R A

    1. Serum-induced sensitization of cyclic AMP accumulation in 1321N1 human astrocytoma cells.
      R A Johnson, L J Arneson-Rotert, J M Hoffman and M L Toews
      Molecular Pharmacology March 1991, 39 (3) 399-406;

  2. Jordan, V C

    1. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
      C S Murphy, C J Parker, R McCague and V C Jordan
      Molecular Pharmacology March 1991, 39 (3) 421-428;

K

  1. Kanterman, R Y

    1. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
      R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
      Molecular Pharmacology March 1991, 39 (3) 364-369;

  2. Kauffman, F C

    1. Futile cycling of a sulfate conjugate by isolated hepatocytes.
      F C Kauffman, M Whittaker, I Anundi and R G Thurman
      Molecular Pharmacology March 1991, 39 (3) 414-420;

  3. Kinouchi, K

    1. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
      K M Standifer, L R Murthy, K Kinouchi, L Steele and G W Pasternak
      Molecular Pharmacology March 1991, 39 (3) 290-298;

  4. Klijn, K

    1. Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
      K Klijn, S R Slivka, K Bell and P A Insel
      Molecular Pharmacology March 1991, 39 (3) 407-413;

  5. Kopecka, H

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  6. Kraner, J C

    1. Induction of cytochrome P450IIE1 in the obese overfed rat.
      J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran
      Molecular Pharmacology March 1991, 39 (3) 275-280;

  7. Kroll, J J

    1. Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.
      L M Iwaniec, J J Kroll, W M Roethel and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 299-306;

  8. Kuhar, M J

    1. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
      J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar
      Molecular Pharmacology March 1991, 39 (3) 339-345;

L

  1. Lasker, J M

    1. Induction of cytochrome P450IIE1 in the obese overfed rat.
      J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran
      Molecular Pharmacology March 1991, 39 (3) 275-280;

  2. Lawrence, T S

    1. Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.
      C E Dusenbury, M A Davis, T S Lawrence and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 285-289;

  3. Legendre, P

    1. Noncompetitive inhibition of gamma-aminobutyric acidA channels by Zn.
      P Legendre and G L Westbrook
      Molecular Pharmacology March 1991, 39 (3) 267-274;

  4. Lewin, A H

    1. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
      J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar
      Molecular Pharmacology March 1991, 39 (3) 339-345;

  5. Lieber, C S

    1. Induction of cytochrome P450IIE1 in the obese overfed rat.
      J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran
      Molecular Pharmacology March 1991, 39 (3) 275-280;

  6. Lin, C W

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  7. Lin, F H

    1. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
      F H Lin, G Clark, L S Birnbaum, G W Lucier and J A Goldstein
      Molecular Pharmacology March 1991, 39 (3) 307-313;

  8. Lucier, G W

    1. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
      F H Lin, G Clark, L S Birnbaum, G W Lucier and J A Goldstein
      Molecular Pharmacology March 1991, 39 (3) 307-313;

M

  1. Mahan, L C

    1. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
      R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
      Molecular Pharmacology March 1991, 39 (3) 364-369;

  2. Mash, D

    1. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
      Y Itzhak, D Mash, S H Zhang and I Stein
      Molecular Pharmacology March 1991, 39 (3) 385-393;

  3. Matsumoto, K

    1. Carbachol activates a novel sodium current in isolated guinea pig ventricular myocytes via M2 muscarinic receptors.
      K Matsumoto and A J Pappano
      Molecular Pharmacology March 1991, 39 (3) 359-363;

  4. Maybaum, J

    1. Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.
      C E Dusenbury, M A Davis, T S Lawrence and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 285-289;
    2. Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.
      L M Iwaniec, J J Kroll, W M Roethel and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 299-306;

  5. McCague, R

    1. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
      C S Murphy, C J Parker, R McCague and V C Jordan
      Molecular Pharmacology March 1991, 39 (3) 421-428;

  6. Miller, K W

    1. Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo.
      S C Wood, S A Forman and K W Miller
      Molecular Pharmacology March 1991, 39 (3) 332-338;

  7. Miller, T R

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  8. Monsma, F J

    1. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
      R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
      Molecular Pharmacology March 1991, 39 (3) 364-369;

  9. Murphy, C S

    1. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
      C S Murphy, C J Parker, R McCague and V C Jordan
      Molecular Pharmacology March 1991, 39 (3) 421-428;

  10. Murthy, L R

    1. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
      K M Standifer, L R Murthy, K Kinouchi, L Steele and G W Pasternak
      Molecular Pharmacology March 1991, 39 (3) 290-298;

N

  1. Nadzan, A M

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  2. Nettleton, J

    1. Block of single batrachotoxin-activated Na+ channels by clofilium.
      J Nettleton, N A Castle and G K Wang
      Molecular Pharmacology March 1991, 39 (3) 352-358;

P

  1. Pappano, A J

    1. Carbachol activates a novel sodium current in isolated guinea pig ventricular myocytes via M2 muscarinic receptors.
      K Matsumoto and A J Pappano
      Molecular Pharmacology March 1991, 39 (3) 359-363;

  2. Parker, C J

    1. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
      C S Murphy, C J Parker, R McCague and V C Jordan
      Molecular Pharmacology March 1991, 39 (3) 421-428;

  3. Pasternak, G W

    1. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
      K M Standifer, L R Murthy, K Kinouchi, L Steele and G W Pasternak
      Molecular Pharmacology March 1991, 39 (3) 290-298;

  4. Philip, A

    1. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
      J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar
      Molecular Pharmacology March 1991, 39 (3) 339-345;

Q

  1. Quik, M

    1. Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
      M Quik, H el-Bizri, T Audhya and G Goldstein
      Molecular Pharmacology March 1991, 39 (3) 324-331;

R

  1. Rahman, M A

    1. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
      J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar
      Molecular Pharmacology March 1991, 39 (3) 339-345;

  2. Raucy, J L

    1. Induction of cytochrome P450IIE1 in the obese overfed rat.
      J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran
      Molecular Pharmacology March 1991, 39 (3) 275-280;

  3. Roethel, W M

    1. Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.
      L M Iwaniec, J J Kroll, W M Roethel and J Maybaum
      Molecular Pharmacology March 1991, 39 (3) 299-306;

S

  1. Salazar, D E

    1. Induction of cytochrome P450IIE1 in the obese overfed rat.
      J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran
      Molecular Pharmacology March 1991, 39 (3) 275-280;

  2. Schwartz, R D

    1. cAMP analogs inhibit gamma-aminobutyric acid-gated chloride flux and activate protein kinase A in brain synaptoneurosomes.
      R D Schwartz, G Heuschneider, P P Edgar and J A Cohn
      Molecular Pharmacology March 1991, 39 (3) 370-375;

  3. Shiosaki, K

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  4. Sibley, D R

    1. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
      R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
      Molecular Pharmacology March 1991, 39 (3) 364-369;

  5. Slivka, S R

    1. Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
      K Klijn, S R Slivka, K Bell and P A Insel
      Molecular Pharmacology March 1991, 39 (3) 407-413;

  6. Standifer, K M

    1. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
      K M Standifer, L R Murthy, K Kinouchi, L Steele and G W Pasternak
      Molecular Pharmacology March 1991, 39 (3) 290-298;

  7. Steele, L

    1. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
      K M Standifer, L R Murthy, K Kinouchi, L Steele and G W Pasternak
      Molecular Pharmacology March 1991, 39 (3) 290-298;

  8. Stein, I

    1. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
      Y Itzhak, D Mash, S H Zhang and I Stein
      Molecular Pharmacology March 1991, 39 (3) 385-393;

T

  1. Thurman, R G

    1. Futile cycling of a sulfate conjugate by isolated hepatocytes.
      F C Kauffman, M Whittaker, I Anundi and R G Thurman
      Molecular Pharmacology March 1991, 39 (3) 414-420;

  2. Toews, M L

    1. Serum-induced sensitization of cyclic AMP accumulation in 1321N1 human astrocytoma cells.
      R A Johnson, L J Arneson-Rotert, J M Hoffman and M L Toews
      Molecular Pharmacology March 1991, 39 (3) 399-406;

  3. Torphy, T J

    1. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
      T J Torphy, H L Zhou, M Burman and L B Huang
      Molecular Pharmacology March 1991, 39 (3) 376-384;

W

  1. Wagenaar, F

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  2. Wang, G K

    1. Block of single batrachotoxin-activated Na+ channels by clofilium.
      J Nettleton, N A Castle and G K Wang
      Molecular Pharmacology March 1991, 39 (3) 352-358;

  3. Westbrook, G L

    1. Noncompetitive inhibition of gamma-aminobutyric acidA channels by Zn.
      P Legendre and G L Westbrook
      Molecular Pharmacology March 1991, 39 (3) 267-274;

  4. Whittaker, M

    1. Futile cycling of a sulfate conjugate by isolated hepatocytes.
      F C Kauffman, M Whittaker, I Anundi and R G Thurman
      Molecular Pharmacology March 1991, 39 (3) 414-420;

  5. Witte, D G

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  6. Wolfram, C A

    1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
      C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
      Molecular Pharmacology March 1991, 39 (3) 346-351;

  7. Wood, S C

    1. Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo.
      S C Wood, S A Forman and K W Miller
      Molecular Pharmacology March 1991, 39 (3) 332-338;

Z

  1. Zeugin, T

    1. Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.
      J Huwyler, M Bürgin, T Zeugin and J Gut
      Molecular Pharmacology March 1991, 39 (3) 314-323;

  2. Zhang, S H

    1. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
      Y Itzhak, D Mash, S H Zhang and I Stein
      Molecular Pharmacology March 1991, 39 (3) 385-393;

  3. Zhou, H L

    1. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
      T J Torphy, H L Zhou, M Burman and L B Huang
      Molecular Pharmacology March 1991, 39 (3) 376-384;
Back to top

In this issue